Feature Channels

Digestive Disorders

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Keywords:

Hepatitis C Treatment Breakthroughs, Advances in Fecal Microbiota Transplantation for C. difficile, Drug-Induced Liver Injury Warnings among Featured Topics Presented at the American College of Gastroenterology’s 79th Annual Meeting

Promising new research in the area of hepatitis C (HCV) therapy that suggests more patients, including those with cirrhosis, will be cured from this common cause of potentially fatal viral liver disease; as well as a number of abstracts that advance understanding of the safety and effectiveness of fecal microbiota transplantation for Clostridium difficile, are among the highlights of ACG 2014, which will be held this week in Philadelphia.

View | Comment

Medicine

Channels:

Keywords:

Virtual Press Briefings Feature Renowned GI Experts’ Commentary, Real-Word Perspective on Key Science Presented at the American College of Gastroenterology’s 79th Annual Meeting

In a series of virtual press briefings, renowned experts in the field of gastroenterology offer commentary and real word perspective on the key science presented this week at the American College of Gastroenterology's (ACG) 79th Annual Scientific Meeting in Philadelphia.

View | Comment

Medicine

Channels:

ACG 2014 Virtual Press Briefing: Hepatitis C

624668.image1.jpg

This year the College offers a series of pre-recorded virtual press briefings which feature the insights of leading gastroenterology experts on several key abstracts that will be unveiled at ACG 2014 in the areas related to hepatitis C

View | Comment

Medicine

Channels:

ACG 2014 Virtual Press Briefing: Inflammatory Bowel Disease (IBD)

624672.image1.jpg

This year the College offers a series of pre-recorded virtual press briefings which feature the insights of leading gastroenterology experts on several key abstracts that will be unveiled at ACG 2014 in the areas related to inflammatory bowel disease.

View | Comment

Medicine

Channels:

ACG 2014 Virtual Press Briefing: Health “No Nos”

624673.image1.jpg

This year the College offers a series of pre-recorded virtual press briefings which feature the insights of leading gastroenterology experts on several key abstracts that will be unveiled at ACG 2014 in the areas related to notable case reports related to protein shakes, chia seeds, and other supplementation where good health intentions go bad

View | Comment

Medicine

Channels:

ACG 2014 Virtual Press Briefing: Drug Induced Liver Injury and Non-Alcoholic Fatty Liver Disease (NAFLD)

624674.image1.jpg

This year the College offers a series of pre-recorded virtual press briefings which feature the insights of leading gastroenterology experts on several key abstracts that will be unveiled at ACG 2014 in the areas related to drug induced liver injury.

View | Comment

Medicine

Channels:

ACG 2014 Virtual Press Briefing: Fecal Microbiota Transplantation and C. difficile

624676.image1.jpg

This year the College offers a series of pre-recorded virtual press briefings which feature the insights of leading gastroenterology experts on several key abstracts that will be unveiled at ACG 2014 in the areas related to fecal microbiota transplantation and C. difficile.

View | Comment

Medicine

Channels:

Keywords:

Males with IBS Report More Social Stress Than Females

LacknerPortrait.jpg

One of the few studies to examine gender differences among patients with irritable bowel syndrome (IBS) has found that males with the condition experience more interpersonal difficulties than do females with the condition.

View | Comment

Medicine

Channels:

Keywords:

Scientists Discover Pain Receptor on T-Cells

t_cells_left_right.jpg

Researchers at University of California, San Diego School of Medicine have discovered that T-cells – a type of white blood cell that learns to recognize and attack microbial pathogens – are activated by a pain receptor.

View | Comment

Medicine

Channels:

Keywords:

Proactive Monitoring Of Inflammatory Bowel Disease Therapy Could Prolong Effectiveness

Proactive monitoring and dose adjustment of infliximab, a medication commonly used to treat inflammatory bowel disease (IBD), could improve a patient’s chances of having a long-term successful response to therapy, a pilot observational study at Beth Israel Deaconess Medical Center concludes.

View | Comment